• A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy
• A Nonredundant Role for the TRPM6 Channel in Neural Tube Closure
• A novel <em>CLDN16</em> mutation in familial hypomagnesemia with hypercalciuria and nephrocalcinosis

• A novel claudin-16 mutation, severe bone disease, and nephrocalcinosis
• A novel CLDN16 mutation in a large family with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis
• A Practical Approach to Hypocalcaemia in Children
• A simplified protocol of regional citrate anticoagulation with phosphate-containing solutions in infants and children treated with continuous kidney replacement therapy
• A young man with recurrent paralysis
• Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study
• Admission serum magnesium levels and the risk of acute respiratory failure
• Analysis of Factors Influencing the Development of Hypomagnesemia in Patients Receiving Cetuximab Therapy for Head and Neck Cancer
• Antibody-mediated inhibition of EGFR reduces phosphate excretion and induces hyperphosphatemia and mild hypomagnesemia in mice
• Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study
• Association of Serum Magnesium with Gastrointestinal Bleeding in Peritoneal Dialysis Patients: a Multicentre Retrospective Study
• Automatic reflex addition of serum magnesium determination to samples with severe hypocalcemia is an effective tool to detect and treat hypomagnesemia
• Characterization of two novel mutations in the claudin-16 and claudin-19 genes that cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis
• Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis
• Chronic Mg²⁺ Deficiency Does Not Impair Insulin Secretion in Mice
• Chvostek's sign in paediatric practice
• Claudin 19-based familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a sibling pair
• Claudins and mineral metabolism
• Comparison of electrolytic status (Na+, K+, Ca2+, Mg2+) in preterm and term deliveries
• Considerations about the molecular basis of some kidney tubule disorders in relation to inbreeding and population displacement
• Diagnostic strategy for inherited hypomagnesemia
• Disturbances of calcium homeostasis in a child with acute lymphoblastic leukemia
• Early initiation of sodium-glucose linked transporter inhibitors (SGLT-2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients
• Effect of magnesium supplementation on insulin resistance in humans: A systematic review
• Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer
• Efficacy, Safety, and Tolerability of Oral Furosemide Among Patients Receiving Hemodialysis: A Pilot Study
• Electrolytes
• Establishment of urinary exosome-like vesicles isolation protocol for FHHNC patients and evaluation of different exosomal RNA extraction methods
• Evaluation of standard versus prolonged magnesium infusion rates in hospitalized patients: a retrospective cohort study
• Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations
• Extreme hypomagnesemia: characteristics of 119 consecutive inpatients
• Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. Its history
• Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: variable phenotypic expression in three affected sisters from Mexican ancestry
• Furosemide rescues hypercalciuria in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis model
• Genetic causes of hypomagnesemia, a clinical overview
• Gitelman syndrome associated with chondrocalcinosis and severe neuropathy: a novel heterozygous mutation in SLC12A3 gene
• Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects
• Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease
• Hypomagnesaemia, cardiovascular-renal negative effects and Gitelman's syndrome: A paradox awaiting resolution
• Hypomagnesemia and mortality in patients admitted to intensive care unit: a systematic review and meta-analysis
• Hypomagnesemia and proton-pump inhibitors
• Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin
• Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants
• Hypomagnesemia in Intracerebral Hemorrhage
• Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients
• Hypomagnesemia is associated with increased mortality in the short-term but not the long-term in community-acquired pneumonia patients with type 2 diabetes
• Hypomagnesemia with Hypercalciuria Leading to Nephrocalcinosis, Amelogenesis Imperfecta, and Short Stature in a Child Carrying a Homozygous Deletion in the CLDN16 Gene
• Identification of SLC41A3 as a novel player in magnesium homeostasis
• Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab
• Importance of magnesium sulfate supplementation in the prevention of hypomagnesemia and hypocalcemia during chemoradiation in head and neck cancer
• In-Depth Bioinformatic Study of the CLDN16 Gene and Protein: Prediction of Subcellular Localization to Mitochondria
• Incidence of ionized hypomagnesemia in adult patients undergoing noncardiac major surgery: a prospective observational trial
• Increasing interest strategies to appropriately measure of serum magnesium: An opportunity for clinical laboratories to further unmask hypomagnesemia
• Inherited and acquired disorders of magnesium homeostasis
• Inherited disorders of renal hypomagnesaemia
• Magnesium in the treatment of alcohol withdrawal syndrome: a multicenter randomized controlled trial
• Magnesium, calcium and potassium: "no one was born alone"
• Mechanisms and causes of hypomagnesemia
• Mg2+ homeostasis: the balancing act of TRPM6
• Mineral Disorders in Adult Inpatients Receiving Parenteral Nutrition. Is Older Age a Contributory Factor?
• Modification of Total Magnesium level in pregnant Saudi Women developing gestational diabetes mellitus
• Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians
• mTOR-Activating Mutations in <em>RRAGD</em> Are Causative for Kidney Tubulopathy and Cardiomyopathy
• Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting
• Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving cisplatin
• Novel mutations in TRPM6 gene associated with primary hypomagnesemia with secondary hypocalcemia. Case report
• Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial
• Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study
• Persistent dyselectrolytemia in a neonate induced by liposomal amphotericin B. A case report
• Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: A frequent association?
• Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study
• Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran
• Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study
• Proton Pump Inhibitors and Hypomagnesemia in Older Inpatients: An Observational Study
• Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults
• Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use
• Proton pump inhibitors: Understanding the associated risks and benefits of long-term use
• Rather Unusual Cause of Seizures
• Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia
• Relation of Low Serum Magnesium to Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation
• Renal function of cyclin M2 Mg2+ transporter maintains blood pressure
• Research progress on renal calculus associate with inborn error of metabolism
• Retrospective cohort study of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations
• Review: UPDATE on magnesium metabolism
• Seizures in eating disorders
• Serum calcium and magnesium levels in women presenting with pre-eclampsia and pregnancy-induced hypertension: a case-control study in the Cape Coast metropolis, Ghana
• Severe Torsades de Pointes with acquired QT prolongation
• Short-Term Effect of High-Dose Pantoprazol on Serum and Urinary Magnesium Levels
• Single High-dose of Liposomal Amphotericin B in HIV/AIDS-related Disseminated Histoplasmosis: a Randomized Trial
• Spectrum of Disorders associated with Tetany
• The emerging roles and therapeutic potential of cyclin M/CorC family of Mg²⁺ transporters
• The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study
• The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism
• The Incidence of Cisplatin-induced Hypomagnesemia in Cervical Cancer Patients Receiving Cisplatin Alone
• Ultrastructural intestinal mucosa change after prolonged inhibition of gastric acid secretion by omeprazole in male rats
• Unrecognized Primary Hypoparathyroidism with Severe Hypocalcemia in the Presence of COVID-19 Infection
• Usefulness of laboratory and radiological investigations in the management of supraventricular tachycardia